| Primla Fazalud-din, MD | |
|
31 Sycamore St, Glastonbury, CT 06033-4540 | |
| (860) 714-2750 | |
| (860) 714-8591 |
| Full Name | Primla Fazalud-din |
|---|---|
| Gender | Female |
| Speciality | Psychiatry & Neurology - Psychiatry |
| Location | 31 Sycamore St, Glastonbury, Connecticut |
| Accepts Medicare Assignments | Does not participate in Medicare Program. She may not accept medicare assignment. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1679589956 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 2084P0800X | Psychiatry & Neurology - Psychiatry | 024019 (Connecticut) | Primary |
| Mailing Address | Practice Location Address |
|---|---|
| Primla Fazalud-din, MD 675 Tower Avenue, Suite 301, Hartford, CT 06112 Ph: (860) 714-2750 | Primla Fazalud-din, MD 31 Sycamore St, Glastonbury, CT 06033-4540 Ph: (860) 714-2750 |
News Archive
Pharmatech initiated enrollment for its AccessPPM program after a two-year investment into this game-changing method for matching cancer patients to cancer clinical trials.
A new study has utilized a novel method to estimate long-term ozone exposure and previously reported epidemiological results to quantify the health burden from long-term ozone exposure in three major regions of the world.
The Association of Community Cancer Centers announced that results of a landmark study of how—and how well—the cancer patient's transition from the hospital inpatient setting to outpatient oncology group is managed. The study, designed to help hospitals and oncology groups improve their transition processes. The study was conducted by the Association of Community Cancer Centers, was conducted by ACCC, with strategic research and analysis provided by Health2 Resources.
People with rare diseases have the same right to high-quality health care in line with current medical knowledge as other patients do. However, relevant and reliable clinical studies on rare diseases are often lacking. Among other things, this makes the development of corresponding guidelines more difficult, but precisely such guidelines could help improve treatment quality.
› Verified 1 days ago
Dr. Audrey Garrett, M.D. Psychiatry & Neurology Medicare: Not Enrolled in Medicare Practice Location: 55 Nye Rd, Suite 102, Glastonbury, CT 06033 Phone: 860-657-3056 Fax: 860-633-3517 | |
Richard Alan Miller, MD Psychiatry & Neurology Medicare: Not Enrolled in Medicare Practice Location: 122 A Naubuc Avenue, Glastonbury, CT 06033 Phone: 860-657-3799 | |
Dr. Milind Kale, M.D. Psychiatry & Neurology Medicare: Medicare Enrolled Practice Location: 140 Glastonbury Blvd Ste 30, Glastonbury, CT 06033 Phone: 860-561-5453 Fax: 860-371-2527 | |
Dr. Claudia Mary Carbonari, M.D. Psychiatry & Neurology Medicare: Not Enrolled in Medicare Practice Location: 39 Hampshire Dr, Glastonbury, CT 06033 Phone: 860-633-9522 Fax: 860-657-3667 | |
Mark Weremchuk, MD Psychiatry & Neurology Medicare: Not Enrolled in Medicare Practice Location: 210 New London Tpke, Glastonbury, CT 06033 Phone: 860-633-1543 Fax: 860-659-9755 | |
Dr. Ian Richard Cameron, M.D. Psychiatry & Neurology Medicare: Not Enrolled in Medicare Practice Location: 200 Oak St, Glastonbury, CT 06033 Phone: 860-657-3602 Fax: 860-657-4421 | |
Evan Fox, MD Psychiatry & Neurology Medicare: Accepting Medicare Assignments Practice Location: 300 Hebron Ave, Suite 107, Glastonbury, CT 06033 Phone: 860-430-1150 Fax: 860-430-1093 |